BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22103978)

  • 1. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.
    Chen L; Mao YP; Xie FY; Liu LZ; Sun Y; Tian L; Tang LL; Lin AH; Li L; Ma J
    Radiother Oncol; 2012 Sep; 104(3):331-7. PubMed ID: 22103978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
    Zong J; Lin S; Lin J; Tang L; Chen B; Zhang M; Zhang Y; Xu L; Chen Y; Xiao Y; Fang Y; Pan J
    Oral Oncol; 2015 Mar; 51(3):254-9. PubMed ID: 25467207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
    Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
    BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.
    Li J; Zou X; Wu YL; Guo JC; Yun JP; Xu M; Feng QS; Chen LZ; Bei JX; Zeng YX; Chen MY
    PLoS One; 2014; 9(12):e116261. PubMed ID: 25536307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.
    Kang M; Long J; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
    Oncotarget; 2016 Mar; 7(12):15252-61. PubMed ID: 26918446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Kang M; Zhou P; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
    Oncotarget; 2017 Sep; 8(41):70586-70594. PubMed ID: 29050304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.
    Tang LL; Chen YP; Mao YP; Wang ZX; Guo R; Chen L; Tian L; Lin AH; Li L; Sun Y; Ma J
    J Natl Compr Canc Netw; 2017 Jul; 15(7):913-919. PubMed ID: 28687579
    [No Abstract]   [Full Text] [Related]  

  • 9. A Study of 358 Cases of Locally Advanced Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiation Therapy: Improving the Seventh Edition of the American Joint Committee on Cancer T-Staging System.
    Zhou Q; He Y; Zhao Y; Wang Y; Kuang W; Shen L
    Biomed Res Int; 2017; 2017():1419676. PubMed ID: 28265567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
    Kang M; Zhou P; Liao X; Xu M; Wang R
    Oral Oncol; 2017 Dec; 75():100-105. PubMed ID: 29224805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy.
    Liang ZG; Chen XQ; Niu ZJ; Chen KH; Li L; Qu S; Su F; Zhao W; Li Y; Pan XB; Zhu XD
    PLoS One; 2016; 11(12):e0168470. PubMed ID: 27973544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Chan LL; O'Sullivan B; Lin SJ; Sze HC; Chen YB; Choi HC; Guo QJ; Kan WK; Xiao YP; Wei X; Le QT; Glastonbury CM; Colevas AD; Weber RS; Shah JP; Lee AW
    Cancer; 2016 Feb; 122(4):546-58. PubMed ID: 26588425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
    Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
    Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.
    He T; Yan RN; Chen HY; Zeng YY; Xiang ZZ; Liu F; Shao BF; Ma JC; Wang XR; Liu L
    BMC Cancer; 2021 Mar; 21(1):327. PubMed ID: 33785010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinoma.
    Sun R; Qiu HZ; Mai HQ; Zhang Q; Hong MH; Li YX; Yang J; Sun J; Mo HY
    J Cancer Res Clin Oncol; 2013 Feb; 139(2):307-14. PubMed ID: 23070122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.
    Wu LR; Zhang XM; Xie XD; Lu Y; Wu JF; He X
    Oral Oncol; 2019 Nov; 98():141-146. PubMed ID: 31586896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
    Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement.
    Lee AWM; Ng WT; Chan LK; Chan OSH; Hung WM; Chan CC; Cheng PTC; Sze H; Lam TS; Yau TK
    Oral Oncol; 2012 Oct; 48(10):1007-1013. PubMed ID: 22525607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging.
    Mao YP; Xie FY; Liu LZ; Sun Y; Li L; Tang LL; Liao XB; Xu HY; Chen L; Lai SZ; Lin AH; Liu MZ; Ma J
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1326-34. PubMed ID: 19153016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
    Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
    Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.